Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|October 28, 2025
Glaucoma diagnosis and treatment in the era of precision medicineSara Labay-Tejado, Mercè Brunet, Elena Milla
The Journal of Clinical Psychiatry|April 21, 2004
Risperidone in the treatment of patients with deliriumEduard Parellada, Inmaculada Baeza, Joan de Pablo, et al.
Therapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of mTOR InhibitorsOlga Millán, Eberhard Wieland, Pierre Marquet, et al.
Therapeutic Drug Monitoring|October 8, 2015
T-Cell Cytokines as Predictive Markers of the Risk of Allograft RejectionMercè Brunet, Olga Millán López, Marcos López-Hoyos
International Clinical Psychopharmacology|March 23, 2010
Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disordersEduard Parellada, Filippos Kouniakis, Aldona Siurkute, et al.
Advances in Laboratory Medicine|December 18, 2023
Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactionsJaime I Sainz de Medrano Sainz, Mercè Brunet Serra
Enfermedades Infecciosas Y Microbiologia Clinica|May 1, 2012
Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipientsSoledad Berdaguer, Javier Bautista, Mercè Brunet, et al.
International Journal of Psychiatry in Clinical Practice|November 23, 2017
An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study)Eduard Parellada, Miquel Bioque, Manuel Serrano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2019
Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipientsOlga Millán, Pablo Ruiz, Virginia Fortuna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cellsPatricia Gassó, Sergi Mas, Oriol Molina, et al.
Pageof 14